Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofia Ramiro

Showing results (101-110 of 287) with videos related to

Pageof 29
Sort By:
Joint Bone Spine|March 27, 2026
Nonsteroidal Anti-Inflammatory Drug Use and Incident Hypertension in Axial Spondyloarthritis: Data from DESIRJose A Meade-Aguilar, Rachael Stovall, Sofia Ramiro, et al.
Seminars in Arthritis and Rheumatism|March 27, 2020
Integrated longitudinal analysis does not compromise precision and reduces bias in the study of imaging outcomes: A comparative 5-year analysis in the DESIR cohortAlexandre Sepriano, Sofia Ramiro, Désirée van der Heijde, et al.
Arthritis Care & Research|September 25, 2020
Imaging Outcomes for Axial Spondyloarthritis and Sensitivity to Change: A Five-Year Analysis of the DESIR CohortAlexandre Sepriano, Sofia Ramiro, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)|August 14, 2016
Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitisIvette Essers, Annelies Boonen, Matthias Busch, et al.
RMD Open|June 22, 2023
Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task forceCatalina Sanchez-Alvarez, Milena Bond, Medha Soowamber, et al.
Clinical Rheumatology|November 13, 2025
Cost optimizing tocilizumab therapy in stable rheumatoid arthritis: a dose de-escalation nomogram to prevent overuse and unnecessary costsKaja van Soest, Sofia Ramiro, Mirian J F Starmans-Kool, et al.
Annals of the Rheumatic Diseases|October 19, 2022
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritisAugusta Ortolan, Casper Webers, Alexandre Sepriano, et al.
The Journal of Rheumatology|November 1, 2022
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature ReviewGonçalo Boleto, Alvise Berti, Peter A Merkel, et al.
Arthritis Research & Therapy|August 8, 2022
A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritisRubén Burgos-Vargas, Adalberto Loyola-Sanchez, Sofia Ramiro, et al.
The Journal of Rheumatology|June 17, 2018
Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR RegisterSytske Anne Bergstra, Cornelia F Allaart, Sofia Ramiro, et al.
Pageof 29

Showing results (101-110 of 287) with videos related to

Sort By:
Pageof 29
Joint Bone Spine|March 27, 2026
Nonsteroidal Anti-Inflammatory Drug Use and Incident Hypertension in Axial Spondyloarthritis: Data from DESIRJose A Meade-Aguilar, Rachael Stovall, Sofia Ramiro, et al.
Seminars in Arthritis and Rheumatism|March 27, 2020
Integrated longitudinal analysis does not compromise precision and reduces bias in the study of imaging outcomes: A comparative 5-year analysis in the DESIR cohortAlexandre Sepriano, Sofia Ramiro, Désirée van der Heijde, et al.
Arthritis Care & Research|September 25, 2020
Imaging Outcomes for Axial Spondyloarthritis and Sensitivity to Change: A Five-Year Analysis of the DESIR CohortAlexandre Sepriano, Sofia Ramiro, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)|August 14, 2016
Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitisIvette Essers, Annelies Boonen, Matthias Busch, et al.
RMD Open|June 22, 2023
Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task forceCatalina Sanchez-Alvarez, Milena Bond, Medha Soowamber, et al.
Clinical Rheumatology|November 13, 2025
Cost optimizing tocilizumab therapy in stable rheumatoid arthritis: a dose de-escalation nomogram to prevent overuse and unnecessary costsKaja van Soest, Sofia Ramiro, Mirian J F Starmans-Kool, et al.
Annals of the Rheumatic Diseases|October 19, 2022
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritisAugusta Ortolan, Casper Webers, Alexandre Sepriano, et al.
The Journal of Rheumatology|November 1, 2022
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature ReviewGonçalo Boleto, Alvise Berti, Peter A Merkel, et al.
Arthritis Research & Therapy|August 8, 2022
A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritisRubén Burgos-Vargas, Adalberto Loyola-Sanchez, Sofia Ramiro, et al.
The Journal of Rheumatology|June 17, 2018
Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR RegisterSytske Anne Bergstra, Cornelia F Allaart, Sofia Ramiro, et al.
Pageof 29